TP53BP2 and pancreatic adenocarcinoma: According to The Cancer Genome Atlas (TCGA) and Genotype Tissue Expression (GTEx) data from the public cancer portal Gene Expression Profiling Interactive Analysis 2 (GEPIA2) [51], ASPP2 mRNA expression is greater in liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), and thymoma (THYM) (Figure 3A,B).